Correction: MIR22HG acts as a tumor suppressor via TGFβ/SMAD signaling and facilitates immunotherapy in colorectal cancer

• Juan Xu,
• Tingting Shao,
• Mingxu Song,
• Yunjin Xie,
• Jialiang Zhou,
• Jiaqi Yin,
• Na Ding,
• Haozhe Zou,
• Yongsheng Li,
• Jiwei Zhang

Affiliations

Juan Xu

Key Laboratory of Tropical Translational Medicine of Ministry of Education, College of Biomedical Information and Engineering, Hainan Medical University

Tingting Shao

College of Bioinformatics Science and Technology, Harbin Medical University

Mingxu Song

Wuxi Oncology Institute, The Affiliated Hospital of Jiangnan University

Yunjin Xie

College of Bioinformatics Science and Technology, Harbin Medical University

Jialiang Zhou

Department of radiation oncology, The Affiliated Hospital of Jiangnan University

Jiaqi Yin

College of Bioinformatics Science and Technology, Harbin Medical University

Na Ding

College of Bioinformatics Science and Technology, Harbin Medical University

Haozhe Zou

College of Bioinformatics Science and Technology, Harbin Medical University

Yongsheng Li

Key Laboratory of Tropical Translational Medicine of Ministry of Education, College of Biomedical Information and Engineering, Hainan Medical University

Jiwei Zhang

The MOE Key Laboratory for Standardization of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Mdicine